Moderna's Vaccine Portfolio Primed For Boost From Its COVID-19 Work

 
• By Brenda Sandburg
  
Stone / United Kingdom - February 11 2020: Moderna medical compamy logo seen on the brochure with the viral masks, syringe and pills. Photo concept. Selective focus.
Moderna touts its messenger RNA and vaccines pipline to investors
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip